Although more robust scientific evidence is needed, the possibility does exist that QPD and XBD may change macrophages’ response to the microenvironment via regulation of pinocytosis, leading to a more favorable prognosis in COVID-19 patients. The gene discussed is PLAU; the disease is COVID-19.